Earticle

초록

영어

This study investigated social relief schemes for serious adverse drug reactions in foreign countries and deduced lessons and implications for Korea to implement the scheme. A social relief scheme for serious adverse drug reactions provides reliefs for diseases and such health effects as disabilities or deaths that were caused by adverse reactions to pharmaceuticals prescribed at hospitals and clinics as well as those purchased at pharmacies notwithstanding their proper use. The US and the UK do not have specific relief schemes for adverse drug reactions but apply rules of strict liability or negligence. New Zealand and Nordic countries provide no-fault compensation schemes for health effects or injuries caused by medical treatments or medicinal products. Japan and Taiwan have operated the schemes since 1980
and 2000, respectively. In designing the scheme in Korea, we suggested that cases eligible for relief be confined to serious adverse reactions such as death or disability and then extended to diseases. It is desirable to encourage the reporting system of adverse drug reactions and quality use of medicines for the relief scheme to work efficiently.

목차

Abstract
 연구방법
 결과
  1. 미국과 영국
  2. 뉴질랜드와 노르딕 국가
  3. 일본
  4. 대만
 국내 제도 실시를 위한 고찰
  1. 국내 제도 실시의 접근방향
  2. 관련 제도 등 여건에 관한 고찰
 결론
 참고문헌

키워드

저자

• 박 실비아 [ Sylvia Park | 한국보건사회연구원 의약품정책팀 ] Correspondence author
• 채수미 [ Su Mi Chae | 한국보건사회연구원 의약품정책팀 ]

참고문헌

발행기관

간행물

표지보기 관심저널 등록

• 간행물명

  한국임상약학회지 [Korean Journal of Clinical Pharmacy]

• 간기

  계간

• pISSN

  1226-6051

• 수록기간

  1991~2026

• 등재여부

  KCI 등재

• 십진분류

  KDC 518 DDC 615